We are live on !
Find out more
Greenleaf Trust Portfolio holdings
AUM
$10.4B
Turnover
16.37%
1-Year Est. Return
0.97%
This Fund
S&P 500
This Quarter Est. Return
+7.03%
1 Year Est. Return
+0.97%
3 Year Est. Return
+37.24%
5 Year Est. Return
+56.69%
10 Year Est. Return
+246.06%
AUM
$10.4B
AUM Growth
+$210M
(+2.1%)
Cap. Flow
-$205M
Cap. Flow % of AUM
Cap. Flow %
-1.97%
Top 10 Holdings %
Top 10 Hldgs %
70.96%
Holding
910
New
106
Increased
328
Reduced
392
Closed
43
Avg Time Held
5.1
years
Top 10 Avg Time Held
6.2
years
Top 20 Avg Time Held
6.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$52M |
| 2 |
Janus Henderson AAA CLO ETF
JAAA
|
+$12.7M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$9.9M |
| 4 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$8.15M |
| 5 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$5.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$224M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$38.3M |
| 3 |
Honeywell
HON
|
+$12.9M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$7.71M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$6.42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 47.87% |
| 2 | Miscellaneous | 30.19% |
| 3 | Technology | 8.1% |
| 4 | Financials | 3.93% |
| 5 | Communication Services | 2.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
626
LG Display
LPL
$2.64B
| $349K | ﹤0.01% |
89,635
+66,781
| +292% | +$307K |
2026 Q1
1 quarter
|
|
627
Moderna
MRNA
$96.6B
| $348K | ﹤0.01% |
4,964
-712
| -13% | -$36.8K |
2026 Q1
1 quarter
|
|
628
Range Resources
RRC
$10.2B
| $346K | ﹤0.01% |
9,307
+201
| +2% | +$8.16K |
2020 Q1
25 quarters
|
|
629
Graco
GGG
$13.1B
| $344K | ﹤0.01% |
4,555
+500
| +12% | +$39.4K |
2023 Q4
10 quarters
|
|
630
Ares Management
ARES
$26.4B
| $344K | ﹤0.01% |
+3,094
| New | +$371K |
2026 Q2
0 quarters
|
|
631
PG&E
PCG
$39.6B
| $343K | ﹤0.01% |
20,375
-189
| -0.9% | -$3.18K |
2022 Q4
14 quarters
|
|
632
Workday
WDAY
$49.2B
| $343K | ﹤0.01% |
2,798
+730
| +35% | +$92.5K |
2022 Q3
15 quarters
|
|
633
Woodward
WWD
$19.1B
| $342K | ﹤0.01% |
805
-8
| -1% | -$3.03K |
2025 Q4
2 quarters
|
|
634
Zoetis
ZTS
$33.1B
| $342K | ﹤0.01% |
4,763
+134
| +3% | +$12.6K |
2017 Q3
35 quarters
|
|
635
Sociedad Química y Minera de Chile
SQM
$17.2B
| $342K | ﹤0.01% |
4,616
+2
| +0% | +$167 |
2020 Q2
24 quarters
|
|
636
Axcelis
ACLS
$3.49B
| $342K | ﹤0.01% |
+1,804
| New | +$268K |
2026 Q2
0 quarters
|
|
637
Pentair
PNR
$8.44B
| $341K | ﹤0.01% |
4,454
+387
| +10% | +$30.6K |
2023 Q2
12 quarters
|
|
638
PVH
PVH
$3.99B
| $341K | ﹤0.01% |
4,596
-84
| -2% | -$7.19K |
2020 Q4
22 quarters
|
|
639
Acuity Brands
AYI
$9.31B
| $340K | ﹤0.01% |
904
+24
| +3% | +$7.12K |
2024 Q1
9 quarters
|
|
640
Pinnacle West Capital
PNW
$12.5B
| $340K | ﹤0.01% |
3,180
+845
| +36% | +$86.4K |
2025 Q4
2 quarters
|
|
641
FedEx Freight
FDXF
$16.4B
| $340K | ﹤0.01% |
+2,250
| New | +$369K |
2026 Q2
0 quarters
|
|
642
Carpenter Technology
CRS
$18.5B
| $339K | ﹤0.01% |
550
+11
| +2% | +$5.18K |
2026 Q1
1 quarter
|
|
643
Deutsche Bank
DB
$59.6B
| $338K | ﹤0.01% |
9,999
+587
| +6% | +$19K |
2025 Q3
3 quarters
|
|
644
Northern Trust Morningstar Global Upstream Natural Resources ETF
GUNR
$7.1B
| $337K | ﹤0.01% |
6,834
-1,825
| -21% | -$98.2K |
2021 Q2
20 quarters
|
|
645
Dimensional International Value ETF
DFIV
$21.9B
| $337K | ﹤0.01% |
+6,234
| New | +$343K |
2026 Q2
0 quarters
|
|
646
Hormel Foods
HRL
$11.3B
| $336K | ﹤0.01% |
13,540
-687
| -5% | -$15.3K |
2025 Q4
2 quarters
|
|
647
Neurocrine Biosciences
NBIX
$14.4B
| $336K | ﹤0.01% |
+1,993
| New | +$296K |
2026 Q2
0 quarters
|
|
648
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67B
| $336K | ﹤0.01% |
4,064
-111
| -3% | -$9.17K |
2020 Q2
24 quarters
|
|
649
Pultegroup
PHM
$21.8B
| $336K | ﹤0.01% |
2,446
-242
| -9% | -$29.4K |
2022 Q4
14 quarters
|
|
650
Hasbro
HAS
$15.4B
| $335K | ﹤0.01% |
4,058
-120
| -3% | -$10.8K |
2024 Q1
9 quarters
|
|
Similar funds
BSL
Greenleaf Trust's Q2 2026 Portfolio in Review
As of Q2 2026, Greenleaf Trust held 910 positions worth $10.4B, up 2.1% from $10.2B the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Greenleaf Trust's Q2 2026 filing shows 106 new, 328 increased, 392 reduced and 43 closed positions. Its largest new stake was AstraZeneca: 12,478 shares worth $2.37M. The largest sale was Stryker, an estimated $224M.
By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 53% a quarter earlier, followed by Miscellaneous and Technology.
- Greenleaf Trust's largest Q2 2026 buy was AstraZeneca: 12,478 shares worth $2.37M.
- Greenleaf Trust added most to State Street SPDR Portfolio S&P 500 ETF in Q2 2026, an estimated $52M increase.
- Greenleaf Trust's biggest Q2 2026 reduction was Stryker, cutting an estimated $224M.
- Greenleaf Trust fully exited Liquidia Corp in Q2 2026, selling an estimated $529K.
- Greenleaf Trust's ten largest holdings make up 71% of its $10.4B portfolio in Q2 2026.
- Greenleaf Trust opened 106 new positions and closed 43 in Q2 2026.
- Greenleaf Trust's portfolio value rose 2.1% quarter-over-quarter to $10.4B.
Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.